Document is current
Any future updates will be listed below
-
Authors
Wesson, Jeffrey A. https://orcid.org/0000-0002-2181-0323
Zenka, Roman
Sherman, Katherine
Eisenhauer, Jessica
Lulich, Jody
Davis, Carley
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (CX-001492)
National Institutes of Health (DK 082550)
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 1 September 2024
First Online: 13 September 2024
Declarations
:
: The authors have no conflicts of interest to report.
: Seven calcium oxalate kidney stones in this study were obtained from de-identified, pathological waste specimens previously characterized at the Mandel International Stone and Molecular Analysis Center (MIS.MAC, Milwaukee, WI, USA) or the National VA Crystal Identification Center (Milwaukee, WI, USA) and were used without first obtaining IRB approval. The Clement J Zablocki VA IRB did approve publication of these data, providing that acknowledgement was included with this acknowledgement of lack of approval by IRB for the initial study. While the VA IRB could not grant retrospective approval for studying these samples, they did agree that the data could be published with appropriate acknowledgement of their origin and lack of IRB approval. Four stones were obtained from newly recruited patients following their presentation for stone removal surgery at Froedtert Hospital under IRB approval (protocol number PRO21952) and were also previously published. All procedures performed in these studies were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. Samples from cats were not collected for the purpose of this study, but represent residual samples obtained after clinical analysis with written permission from their owners.
